Where Atara Biotherapeutics Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Atara Biotherapeutics (NASDAQ:ATRA) stock. These analysts…
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday.
The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500 also fell, dropping, 0.80% to 4,347.67.
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 156.6% to $0.58 during Thursday’s regular session. Trading volume for…
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday.
The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53. The S&P 500 also rose, gaining, 0.16% to 4,389.61.
US Stocks Mostly Flat; Jobless Claims Decline In Latest Week
U.S. stocks traded mostly flat this morning, following the release of jobless claims data.
Following the market opening Thursday, the Dow traded down 0.02% to 34,105.13 while the NASDAQ rose 0.01% to 13,651.18. The S&P 500 also fell, dropping, 0.01% to 4,382.36.
Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares surged 111.9% to $0.4810 in pre-market trading after reporting first-quarter results.
Why Atara Biotherapeutics Shares Are Plummeting Today
Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares are trading lower after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint of confirmed disability improvement (CDI) by expanded disabi
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 72.0% to $0.39 during Thursday’s pre-market session. The market value…
Atara Biotherapeutics Announces Primary Analysis Data From Phase 2 EMBOLD Clinical Trial Of ATA188 In Non-Active Progressive Multiple Sclerosis; Primary Endpoint Of Confirmed Disability Improvement At 12 Months Not Achieved
Primary Endpoint of Confirmed Disability Improvement at 12 Months Not AchievedCompany to Further Analyze Data and Evaluate Strategic Options for ATA188 Program with Focusing of Resources and Planned Expense Reductions